Pacer Swan SOS Moderate April (PSMR)

Has updated timeline 39Z-4 been updated?

SPCX - retail shares are not restricted, but Fidelity may limit access to futures IPOs for those who flip their shares in under 15 days.

The IPO may be oversubscribed, so if you ask for 50 shares you might only get 25.

https://www.businessinsider.com/spacex-ipo-fidelity

🙏🏼🙏🏼🙏🏼 my friend

INTU is near its 52-week low. If the perception among hedge fund managers and other institutional investors is that AI is going to hurt Intuit, it is going to stay down, imo.
The company needs a strong AI strategy.
Also, the dividend yield is not good. IMO, investors are not getting

brazen22,

That is certainly one way of thinking. I personally don’t have a problem with that but there still remains the bigger picture to consider. In my view “the process” and the framework it is built on is the problem creating this kind of dilemma that all parties are required t

th6565. what is your nationality?

“Although Wertheim & Co. no longer exists as an independent entity” ❌

Only Fools are Fooled

https://wertheimandcompany.com/transactions/

Why not? Because you are short and nobody can make coin except you? Try again because you lose here pal!!!

Within in the next 30 days IMO, soon trips are history for good!!!

.007 minimum

What do you think the price will go to?

Nope

Are we still in the quiet period?? LOL!!

Are we still the game changing, jaw dropping, next Lionsgate, tentpole movie, myflix tail that wags the dog, unbelievable movie distributor lol.

17 years of failure buffoon boy CEO.

Jack Wagon CEO!!

Guess there is the problem of numbers in the clientele realm??

It’s been half a year since the ASM. It’s been over two and a half years since the MAA was submitted. It’s been two decades since the phase iii trial appeared on clinicaltrials.gov.

It’s great they are all around the world advocating for cancer vaccines, but we need an update. We

Hopefully soon

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

Lilly's triple agonist, retatrutide, drove substantial improvements in weight, A1C, knee osteoarthritis pain, and obstructive sleep apnea, demonstrating its remarkable potential to treat obesity and its complicationsJune 6, 2026 2:30 PM
PR Newswire (US)

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

It’s about time!!

Interesting development:

MSN has updated the name (not the ticker symbol) ... while OTC website still shows Natama

https://www.msn.com/en-us/money/stockdetails/fi-b19gfr?ocid=msedgntp&id=b19gfr

Well, 55 his to skinny. Sigma pharmaceuticals was not in our wheelhouse. As an advisor to the company, the easiest way that I could say is. The whole Sigma thing went south as soon as the books needed to be audited. They did not want anyone in their business. 
Methylene blue came into the pic

The “as quickly as possible” versus “as many as possible” framing has a problem.

If someone had GBM 2.5 years ago, I doubt they would view delay as acceptable because it might help reach more patients later. For the current GBM population, the fastest path matters.

Appr

Qatar (royals) famous for recent lawful outcomes.

Pulte Related? or Not?
IC3: Industry Alerts
Safeguarding Our Secrets
https://www.ic3.gov/CSA/2026/260603.pdf
June 3, 2026
Full Press Release

________________________________________